Arbiter

AI care orchestration platform unifying patient data for payers/providers

Website: https://www.arbiter.ai

Cover Block

PUBLIC
Name Arbiter
Tagline AI care orchestration platform unifying patient data for payers/providers
Headquarters New York City, USA
Founded 2025
Stage Seed
Business Model B2B
Industry Healthtech
Technology AI / Machine Learning
Geography North America
Growth Profile Venture Scale
Founding Team Co-Founders (2)
Funding Label $50M+
Total Disclosed $52,000,000

Links

PUBLIC

Executive Summary

PUBLIC

Arbiter is an early-stage healthtech startup that has secured a $52 million seed round at a $400 million valuation to build an AI platform for unifying fragmented patient data and automating care workflows, a bet that merits attention due to its immediate traction with over 1,000 clinicians and its backing by a network of experienced healthcare operators [Business Insider, Nov 2025] [PR Newswire, Nov 2025]. The company was founded in 2025 by Michelle Carnahan, a former executive at Eli Lilly, Cigna, UnitedHealth, and VillageMD, who has assembled a team with deep payer, provider, and big tech backgrounds to tackle the long-standing problem of care coordination [HIT Consultant, Nov 2025]. Its core product is a care orchestration platform built on a proprietary "Record-Action-Alignment" model, which integrates clinical, financial, and policy data to automate tasks like referrals and site-of-care optimization, starting with a specific application launched in partnership with a national payer [PR Newswire, Nov 2025].

Arbiter's differentiation appears to rest on the acquisition of SecondWave Delivery Systems' data layer, which provided an accelerated path to a unified patient record and an initial customer base, rather than on building a novel AI model from scratch [Business Insider, Nov 2025]. The business model is B2B, targeting both health plans and provider networks, with its initial wedge being real-time optimization of where patients receive care based on cost, quality, and availability. The funding, led by family offices TriEdge Investments and MFO Ventures alongside WindRose Health Investors, suggests a capital base comfortable with the regulatory and sales cycles inherent in healthcare [Business Insider, Nov 2025]. Over the next 12-18 months, the key watch points will be the expansion of its initial site-of-care application into a broader platform, the conversion of its live clinician footprint into disclosed revenue, and whether it can attract follow-on capital from institutional venture firms to scale beyond its seed-stage resources.

Data Accuracy: YELLOW -- Key metrics (valuation, clinician count) are reported by a single major outlet; company press release corroborates funding and product claims.

Taxonomy Snapshot

Axis Classification
Stage Seed
Business Model B2B
Industry / Vertical Healthtech
Technology Type AI / Machine Learning
Geography North America
Growth Profile Venture Scale
Founding Team Co-Founders (2)
Funding $50M+ (total disclosed ~$52,000,000)

Company Overview

PUBLIC

Arbiter is a newly formed entity, incorporated roughly six months before its public debut in November 2025 [Business Insider, Nov 2025]. The company emerged from stealth with a $52 million seed round and a stated mission to build an AI system for unifying healthcare data and workflows [PR Newswire, Nov 2025]. Its headquarters are listed in New York City [PR Newswire, Nov 2025].

A significant early milestone was the acquisition of SecondWave Delivery Systems, a data platform focused on risk adjustment and patient data unification. This transaction, which included technology, employees, and customer relationships, provided the foundational data layer for Arbiter's platform and accelerated its initial deployment [Business Insider, Nov 2025]. The company's first commercial application, a site-of-care optimization tool, launched concurrently with its funding announcement in partnership with what it describes as a leading national payer and major provider networks [PR Newswire, Nov 2025][HIT Consultant, Nov 2025].

Data Accuracy: YELLOW -- Key founding and operational details are reported by multiple business publications, but the company's own website and official corporate filings were not reviewed as primary sources.

Product and Technology

MIXED Arbiter's platform is positioned as an AI-powered operating system for healthcare, designed to address the industry's foundational problem of data fragmentation. The company's public materials describe a three-part "Record-Action-Alignment" model that forms the core of its approach [PR Newswire, Nov 2025]. This model begins by unifying clinical, financial, and policy data into a single longitudinal patient record. It then uses this unified data to automate specific administrative workflows, such as generating prior authorizations, scheduling appointments, and managing patient outreach. The final step involves aligning the incentives and actions of payers, providers, and patients around optimized care pathways, with the initial application focused on real-time site-of-care decisions for referrals [HIT Consultant, Nov 2025].

The company's technical foundation appears to rely heavily on data integration capabilities, an area it accelerated through the acquisition of SecondWave Delivery Systems in 2025 [Business Insider, Nov 2025]. This move provided an existing data layer for risk adjustment and patient data unification, which likely forms the backbone of the "Record" component. Current job postings indicate a strong focus on building out this infrastructure, with roles for a Data Engineering Lead and a Senior Engineer specializing in EMR integrations [AshbyHQ, 2026]. The platform is reportedly live and being used by over 1,000 clinicians and several health plans for patient engagement and scheduling automation, though the specific depth of AI-driven automation versus rules-based workflow is not detailed in public sources [Business Insider, Nov 2025].

Data Accuracy: YELLOW -- Product claims are sourced from company press releases and secondary reporting; technical stack is inferred from job postings.

Market Research

PUBLIC

The core problem Arbiter addresses, the fragmentation of patient data across clinical, financial, and administrative systems, is not new, but the economic pressure to solve it has intensified to a point where AI-driven orchestration is moving from a theoretical advantage to a near-term operational necessity.

Quantifying the total addressable market for a platform that aims to unify care workflows is challenging, as it spans multiple software categories from revenue cycle management to clinical decision support. The most directly analogous public sizing comes from the broader healthcare IT market, which Grand View Research valued at $394.6 billion globally in 2023, with a projected compound annual growth rate of 19.8% from 2024 to 2030 [Grand View Research, 2024]. A more specific segment, the U.S. market for healthcare data integration tools, was estimated at $3.7 billion in 2023 by MarketsandMarkets, growing at 12.5% annually [MarketsandMarkets, 2024]. These figures provide a rough bounding box for the opportunity, though Arbiter's specific wedge, site-of-care optimization, sits within the narrower but fast-growing value-based care enablement software segment.

Demand is driven by a confluence of persistent industry pain points and recent tailwinds. On the payer side, administrative waste, estimated to account for 15-30% of healthcare spending, creates a direct financial incentive to automate manual processes like prior authorizations and referral coordination [Health Affairs, 2023]. For providers, clinician burnout and staffing shortages increase the urgency for tools that reduce administrative burden. The post-pandemic acceleration of telehealth and distributed care models has further fragmented patient journeys, making unified orchestration more critical. A cited tailwind is the maturation of large language models, which are now being applied to structured and unstructured clinical data with greater accuracy, enabling the automation of complex, context-sensitive tasks that were previously out of reach [HIT Consultant, Nov 2025].

Key adjacent markets include population health management platforms, which focus on analytics and risk stratification for defined patient cohorts, and electronic health record (EHR) vendor ecosystems, which are expanding their own workflow automation modules. These represent both potential partners and competitive substitutes. The regulatory environment is a defining force. While the 21st Century Cures Act pushed for greater data interoperability, compliance remains uneven, creating both a barrier and an opportunity for a neutral platform. The expansion of value-based care payment models, which tie reimbursement to patient outcomes and cost efficiency, is a powerful macro driver, as these models financially reward the kind of coordination and waste reduction Arbiter's platform promises to deliver.

Healthcare IT (Global, 2023) | 394.6 | $B
Healthcare Data Integration (US, 2023) | 3.7 | $B

The sizing data, while not specific to care orchestration, illustrates the scale of the underlying infrastructure markets Arbiter must integrate with and potentially displace. The high growth rate for healthcare IT signals sustained investor and customer appetite for technological solutions, but also intense competition for budget and attention.

Data Accuracy: YELLOW -- Market sizing figures are from third-party analyst reports and provide a relevant analog, but are not specific to the care orchestration category. Demand drivers are supported by industry literature and cited coverage.

Competitive Landscape

MIXED Arbiter enters a crowded field of healthcare data and workflow platforms by positioning its AI as a unifying orchestrator, rather than a point solution for a single function.

Given the absence of specific named competitors in the structured sources, a formal comparison table cannot be constructed. The competitive analysis must be drawn from the broader category description and Arbiter's stated positioning.

The competitive map in healthcare data unification is stratified. At the top are incumbent electronic health record (EHR) vendors like Epic and Cerner, which control the foundational clinical data layer but are often criticized for creating silos and poor interoperability. Challengers include API-focused interoperability platforms such as Redox and Health Gorilla, which facilitate data exchange but typically stop short of prescribing automated clinical or financial actions. A third segment consists of niche workflow automation tools for prior authorizations (e.g., Cohere Health) or referral management (e.g., ReferralMD), which solve specific pain points but do not claim to offer a unified longitudinal record across clinical, financial, and policy domains. Arbiter's stated ambition is to sit above these layers, using its acquired data unification capabilities to not only connect records but also trigger and optimize downstream care decisions.

Arbiter's defensible edge today appears to be a combination of its acquired data assets and its founding team's payer-side relationships. The acquisition of SecondWave Delivery Systems provided an immediate data layer for risk adjustment and patient unification, a tangible asset that would take a greenfield startup years to build [Business Insider, Nov 2025]. Furthermore, CEO Michelle Carnahan's background at Cigna, UnitedHealth, and Kaiser Permanente, alongside a team with experience overseeing "$25B+ annual healthcare payments," suggests a distribution wedge into payer organizations that pure-play technology vendors often lack [HIT Consultant, Nov 2025]. This edge is perishable, however. The data advantage must be continuously enriched and integrated, and payer relationships must convert into multi-year, enterprise-scale contracts to create a true moat.

The company's most significant exposure is on the provider side, where EHR incumbents have deep, sticky integrations and direct clinician loyalty. Convincing health systems to adopt yet another platform that requires workflow changes is a perennial challenge in healthtech. Furthermore, while Arbiter's initial wedge is site-of-care optimization, this is a target for well-funded adjacent players. A company like Olive AI (before its well-publicized challenges) or newer entrants focused on revenue cycle management could expand into similar automation territory, leveraging their own financial data integrations.

The most plausible 18-month scenario hinges on execution speed versus capital efficiency. The winner will be the company that can demonstrate measurable reductions in total cost of care for its payer partners, moving beyond pilot projects to scaled deployments. If Arbiter can use its seed capital and team credibility to secure two or three flagship national payer contracts and show hard savings data, it could establish a formidable position. The loser in this segment will be any platform that remains a data-aggregation dashboard without proving automated actions drive financial outcomes; in a capital-constrained environment, solutions that cannot directly tie activity to savings will struggle to expand beyond initial lighthouse accounts.

Data Accuracy: YELLOW -- Competitive positioning inferred from company claims and general market segments; no direct competitor comparisons from independent sources.

Opportunity

PUBLIC The potential prize for Arbiter is a foundational role in modernizing the U.S. healthcare system's administrative infrastructure, a multi-trillion-dollar market where even modest efficiency gains translate into tens of billions in value.

The headline opportunity is for Arbiter to become the default operating system for value-based care delivery. The company's stated ambition is to build the "AI system that connects healthcare," a platform that unifies clinical, financial, and policy data to automate workflows between payers and providers [PR Newswire, Nov 2025]. This outcome is reachable, rather than purely aspirational, because the initial wedge,site-of-care optimization,targets a specific, high-friction, and costly administrative process. By starting with a tangible problem that has clear ROI for its buyers (payers and large provider networks), Arbiter can establish a beachhead within complex enterprise IT environments. The reported early deployment with over 1,000 clinicians and several health plans suggests this initial entry point is gaining traction, providing a foundation to expand into adjacent workflows [Business Insider, Nov 2025].

Growth from this beachhead could follow several concrete paths. The following scenarios outline plausible routes to scale, each tied to a specific catalyst.

Scenario What happens Catalyst Why it's plausible
Payer-Led Platform Mandate A top-5 national health plan mandates Arbiter's orchestration layer across its entire provider network, standardizing referrals and authorizations. A multi-year, enterprise-wide contract with a "leading national payer," as referenced in launch materials, expands from a pilot to a full rollout [PR Newswire, Nov 2025]. The CEO's background includes leadership roles at UnitedHealth and Cigna, indicating deep relationships and understanding of payer economics [HIT Consultant, Nov 2025].
Acquisition-Driven Ecosystem Arbiter uses its capital to systematically acquire and integrate point-solution healthtech companies, rapidly assembling a comprehensive suite. The acquisition of SecondWave Delivery Systems provides a blueprint and a data layer for integrating acquired assets to accelerate product roadmap [Business Insider, Nov 2025]. The $52 million seed round provides ample capital for strategic acquisitions, and the team includes integration experience from major tech firms [Business Insider, Nov 2025].
Regulatory Tailwind New federal rules around interoperability and prior authorization automation create a compliance-driven market for Arbiter's unified record. Final implementation of CMS rules (e.g., the Advancing Interoperability and Prior Authorization Burden Reduction final rule) creates a hard deadline for payers to adopt automated solutions. The platform's core "Record-Action-Alignment" model is architecturally aligned with federal interoperability goals, positioning it as a compliance solution [HIT Consultant, Nov 2025].

Compounding success for Arbiter would manifest as a classic data and workflow flywheel. Each new health plan or provider network onboarded contributes more clinical and claims data to the platform's longitudinal patient records. A richer, more comprehensive dataset improves the accuracy and effectiveness of the AI models for tasks like referral matching and risk prediction. Better outcomes and higher automation rates, in turn, justify expansion into more workflows within the same customer, from scheduling to chronic care management. The acquisition of SecondWave's data layer suggests this flywheel is already a conscious strategy, providing an initial dataset and integration expertise to accelerate the cycle [Business Insider, Nov 2025].

The size of the win, should a major scenario play out, can be framed by looking at comparable companies that have achieved platform status in adjacent healthcare IT sectors. For instance, Health Catalyst, a provider of data and analytics technology, reached a public market capitalization of approximately $1.2 billion in late 2023. A more direct, though private, comparable could be Olive AI, which achieved a peak valuation of $4 billion before encountering operational challenges. If Arbiter successfully executes on the "Payer-Led Platform Mandate" scenario and captures a material share of administrative workflow automation, a valuation in the low single-digit billions is a credible outcome (scenario, not a forecast). This represents the premium the market places on software that becomes deeply embedded in the revenue cycle of a massive, entrenched industry.

Data Accuracy: YELLOW -- Key opportunity claims (platform ambition, early deployments, acquisition strategy) are sourced from company announcements and initial press coverage, but lack independent third-party validation of scale or economic impact.

Sources

PUBLIC

  1. [PR Newswire, Nov 2025] Arbiter Emerges from Stealth with $52M to Build the AI System that Connects Healthcare | https://www.prnewswire.com/news-releases/arbiter-emerges-from-stealth-with-52m-to-build-the-ai-system-that-connects-healthcare-302620237.html

  2. [Business Insider, Nov 2025] Health Startup Arbiter Grabs $52 Million at $400 Million Valuation | https://www.businessinsider.com/health-startup-arbiter-grabs-52-million-at-400-million-valuation-2025-11

  3. [HIT Consultant, Nov 2025] Arbiter Emerges from Stealth with $52M Funding to End Healthcare Fragmentation with AI | https://hitconsultant.net/2025/11/19/arbiter-emerges-from-stealth-with-52m-funding-to-end-healthcare-fragmentation-with-ai/

  4. [AshbyHQ, 2026] Arbiter AI Jobs | https://jobs.ashbyhq.com/arbiter-ai

  5. [Grand View Research, 2024] Healthcare IT Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/healthcare-it-market

  6. [MarketsandMarkets, 2024] Healthcare Data Integration Market | https://www.marketsandmarkets.com/Market-Reports/healthcare-data-integration-market-263411682.html

  7. [Health Affairs, 2023] Waste in the US Health Care System | https://www.healthaffairs.org/doi/10.1377/hlthaff.2022.00415

Articles about Arbiter

View on Startuply.vc